No evidence of beneficial effects of plasmapheresis in natalizumab-associated PML
暂无分享,去创建一个
D. Centonze | G. Marfia | M. Sormani | D. Landi | R. Capra | F. Mori | L. Prosperini | C. Scarpazza | F. Buttari | S. Zagaglia | M. Albanese | N. de Rossi
[1] Lee A. Tan,et al. Surgical management of malignant cerebral edema secondary to immune reconstitution inflammatory syndrome from natalizumab-associated progressive multifocal encephalopathy , 2015, Journal of Clinical Neuroscience.
[2] H. Lassmann,et al. Progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome (IRIS) , 2015, Acta Neuropathologica.
[3] Predictors of survival and functional outcomes in natalizumab-associated progressive multifocal leukoencephalopathy , 2015, Journal of NeuroVirology.
[4] R. Capra,et al. Early detection and favourable outcome of natalizumab-related progressive multifocal leukoencephalopathy (PML) in two multiple sclerosis patients , 2015, Neurological Sciences.
[5] M. Wattjes,et al. PML-IRIS during Fingolimod Diagnosed after Natalizumab Discontinuation , 2014, Case reports in neurological medicine.
[6] James McIninch,et al. Outcome and survival of asymptomatic PML in natalizumab-treated MS patients , 2014, Annals of clinical and translational neurology.
[7] G. Moonen,et al. Immune Reconstitution Inflammatory Syndrome in Natalizumab-Associated PML , 2012, Neurology.
[8] D. Centonze,et al. Natalizumab therapy of multiple sclerosis: recommendations of the Multiple Sclerosis Study Group—Italian Neurological Society , 2011, Neurological Sciences.
[9] D. Clifford,et al. Natalizumab-associated progressive multifocal leukoencephalopathy. , 2012 .
[10] R. Ransohoff,et al. Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function , 2009, Neurology.
[11] K. Tyler,et al. Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. , 2005, The New England journal of medicine.
[12] S. Atlas,et al. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. , 2005, The New England journal of medicine.